Sign In
test

BRIANNE SHERGILL

Exome Asset Management Llc

Assets Managed
$193.345M
Holdings
55
Last Quarter
2026 - Q1
Filed Date
20d ago
Growth Rate
-7.55%(2Q avg: 9.55%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Exome Asset Management Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 55 positions.

Assets under management

The assets under management (AUM) of Exome Asset Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 193.345M in assets, with a quarterly growth rate of -7.55% and a 2-quarter average growth rate of 9.55%. The portfolio is managed by BRIANNE SHERGILL, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
PRAX
Praxis Precision Medicines I
Recent Activity
Decreased -21.76%
7.58%
$14.65M
45,469 shares@ $322.19 avg price
COGT
Cogent Biosciences Inc
Recent Activity
Decreased -8.84%
5.55%
$10.721M
278,533 shares@ $38.49 avg price
ELVN
Enliven Therapeutics Inc
Recent Activity
Decreased -0.99%
4.47%
$8.628M
220,091 shares@ $39.2 avg price
IONS
Ionis Pharmaceuticals Inc
Recent Activity
Decreased -5.53%
4.28%
$8.265M
110,064 shares@ $75.1 avg price
XBI
Spdr S&p Biotech Etf
Recent Activity
New Position
3.97%
$7.664M↓ Put
60,000 shares@ $127.73 avg price
GH
Guardant Health Inc
Recent Activity
Decreased -15.73%
3.96%
$7.642M
82,736 shares@ $92.37 avg price
CYTK
Cytokinetics Inc
Recent Activity
Decreased -16.85%
3.54%
$6.836M
103,718 shares@ $65.91 avg price
LLY
Eli Lilly & Co
Recent Activity
Decreased -10.69%
3.34%
$6.449M
7,012 shares@ $919.77 avg price
ALMS
Alumis Inc
Recent Activity
Decreased -4.47%
3.19%
$6.15M
279,176 shares@ $22.03 avg price
BBIO
Bridgebio Pharma Inc
Recent Activity
Decreased -16.39%
2.6%
$5.012M
67,492 shares@ $74.27 avg price

1-10 of 55